D008968Concepts & IdeasPhysiologyG02.111.570.82012150.995078Molecular ConformationFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.2268730.010090912research area of0.1809260.029344614subject area for31534310Cotter TG, Jensen DMDrug design, development and therapyGlecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy. Drug Des Devel Ther. 2019; 13:2565-2577.Drug Des Devel Ther2019-07-29T00:00:002019Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy.CarlMakiCarl Maki349531Maki, CarlProfessorDavidWilliamsDavid Lee Williams349574Williams, DavidAssociate ProfessorFredricCohenFredric Cohen41.87432800000000-87.67059170000000349612Cohen, FredricProfessor5Associate Professor4Professor23166324Lauer ME, Glant TT, Mikecz K, DeAngelis PL, Haller FM, Husni ME, Hascall VC, Calabro AThe Journal of biological chemistryIrreversible heavy chain transfer to hyaluronan oligosaccharides by tumor necrosis factor-stimulated gene-6. J Biol Chem. 2013 Jan 04; 288(1):205-14.J Biol Chem2012-11-19T00:00:002012Irreversible heavy chain transfer to hyaluronan oligosaccharides by tumor necrosis factor-stimulated gene-6.25955978Dudev T, Musset B, Morgan D, Cherny VV, Smith SM, Mazmanian K, DeCoursey TE, Lim CScientific reportsSelectivity Mechanism of the Voltage-gated Proton Channel, HV1. Sci Rep. 2015 May 08; 5:10320.Sci Rep2015-05-08T00:00:002015Selectivity Mechanism of the Voltage-gated Proton Channel, HV1.Neurological SciencesAnatomy and Cell BiologyRush University, Rush Medical CollegeDenisEvansDenis Evans41.87724600000000-87.66843480000000349006Evans, DenisProfessortrue1ProfessorProfessortrue1ProfessorProfessorInternal Medicine, Division of Digestive Diseases and NutritionDonaldJensenDonald M. Jensen349747Jensen, DonaldProfessortrue1ProfessorProfessortrue1ProfessorProfessorPhysiology and Biophysics23751159Bonazzi S, Cheng B, Wzorek JS, Evans DAJournal of the American Chemical SocietyTotal synthesis of (-)-nakadomarin A. J Am Chem Soc. 2013 Jun 26; 135(25):9338-41.J Am Chem Soc2013-06-17T00:00:002013Total synthesis of (-)-nakadomarin A.22533781Evans DA, Adams DJ, Kwan EEJournal of the American Chemical SocietyProgress toward the syntheses of (+)-GB 13, (+)-himgaline, and himandridine. new insights into intramolecular imine/enamine aldol cyclizations. J Am Chem Soc. 2012 May 16; 134(19):8162-70.J Am Chem Soc2012-05-03T00:00:002012Progress toward the syntheses of (+)-GB 13, (+)-himgaline, and himandridine. new insights into intramolecular imine/enamine aldol cyclizations.true1Associate ProfessorAssociate ProfessorMicrobial Pathogens and Immunity